Yep, but it's encouraging to see how another pre-r

Quote:

---

Yep, but it's encouraging to see how another pre-revenue biotech with hundreds of millions of shares can go from .08 to $80 in a year.

---

I wouldn't call them a biotech, they're more akin to Herbalife. Even if we are at 34 cents a year from now we would still have a higher share price than RGC will have at that time. One thing we'll almost certainly have in common is both former CEOs being felons.